Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia

NCT02746952 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: UCART19

Sponsor

Institut de Recherches Internationales Servier

Collaborators

[object Object]